Efficacy of Cannabidiol in the Management of Self-injuries in Children and Adolescents With Severe Neurodevelopmental Disorders.

NCT07564245 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Neurodevelopmental Disorders With Severe Self-injuries

Interventions

DRUG: Cannabidiol

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]